No Effect of Serotoninergic Gene Variants on Response to Interpersonal Counseling and Antidepressants in Major Depression
Alessandro Serretti, Chiara Fabbri, Silvia Pellegrini, Stefano Porcelli, Pierluigi Politi, Silvio Bellino, Marco Menchetti, Veronica Mariotti, Cristina Demi, Valentina Martinelli, Marco Cappucciati, Paola Bozzatello, Elena Brignolo, Paolo Brambilla, Chi-Un Pae, Matteo Balestrieri, Diana De Ronchi
Psychiatry Investig. 2013;10(2):180-189.   Published online 2013 May 30     DOI: https://doi.org/10.4306/pi.2013.10.2.180
Genetic variants in major depressive disorder: From pathophysiology to therapy
Xenia Gonda, Peter Petschner, Nora Eszlari, Daniel Baksa, Andrea Edes, Peter Antal, Gabriella Juhasz, Gyorgy Bagdy
Pharmacology & Therapeutics.2019; 194: 22.     CrossRef
Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks
Bharathi S. Gadad, Manish K. Jha, Andrew Czysz, Jennifer L. Furman, Taryn L. Mayes, Michael P. Emslie, Madhukar H. Trivedi
Journal of Affective Disorders.2018; 233: 3.     CrossRef
Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years
G. Voegeli, M. L. Cléry-Melin, N. Ramoz, P. Gorwood
Drugs.2017; 77(18): 1967.     CrossRef
Exposure to pesticide as a risk factor for depression: A population-based longitudinal study in Korea
Sang-Baek Koh, Tae Hui Kim, Seongho Min, Kyungsuk Lee, Dae Ryong Kang, Jung Ran Choi
NeuroToxicology.2017; 62: 181.     CrossRef
Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies
Tristram A. Lett, Henrik Walter, Eva J. Brandl
CNS Drugs.2016; 30(12): 1169.     CrossRef
Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach
Gaël Qesseveur, Anne Cécile Petit, Hai Thanh Nguyen, Lionel Dahan, Romain Colle, Samuel Rotenberg, Isabelle Seif, Pauline Robert, Denis David, Jean-Philippe Guilloux, Alain M. Gardier, Céline Verstuyft, Laurent Becquemont, Emmanuelle Corruble, Bruno P. Gu
Neuropharmacology.2016; 105: 142.     CrossRef
Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders
Sarah G Helton, Falk W Lohoff
Pharmacogenomics.2015; 16(5): 541.     CrossRef
Are there meaningful biomarkers of treatment response for depression?
Barbara Breitenstein, Sandra Scheuer, Florian Holsboer
Drug Discovery Today.2014; 19(5): 539.     CrossRef
Serotonin Transporter Gene: A New Polymorphism May Affect Response to Antidepressant Treatments in Major Depressive Disorder
Yoshihiko Matsumoto, Chiara Fabbri, Silvia Pellegrini, Stefano Porcelli, Pierluigi Politi, Silvio Bellino, Caterina Iofrida, Veronica Mariotti, Erika Melissari, Marco Menchetti, Valentina Martinelli, Marco Cappucciati, Paola Bozzatello, Elena Brignolo, Pa
Molecular Diagnosis & Therapy.2014; 18(5): 567.     CrossRef
Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis
Jian-Yang Lin, Ming-Yan Jiang, Zhou-Mi Kan, Yang Chu
Journal of Affective Disorders.2014; 168: 430.     CrossRef